EBITDA Margin % is calculated as EBITDA divided by its Revenue. Genesis Healthcare's EBITDA for the
three
months ended in Dec. 2020 was $38 Mil. Genesis Healthcare's Revenue for the
three
months ended in Dec. 2020 was $919 Mil. Therefore, Genesis Healthcare's EBITDA margin for the quarter that ended in Dec. 2020 was 4.10%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Genesis Healthcare EBITDA Margin % Related Terms
Genesis Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Genesis Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GENNQ vs AIH, JYNT, AVCO: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Genesis Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genesis Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Genesis Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Genesis Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genesis Healthcare (GENNQ) has a EBITDA Margin % of 4.10% as of Dec. 2020. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Genesis Healthcare and its competitors.
Is Genesis Healthcare's EBITDA Margin % too high?
Genesis Healthcare's current EBITDA Margin % is 4.10%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Genesis Healthcare's value of 4.10% is 59.8% below this industry median. Overall, Genesis Healthcare has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Genesis Healthcare's EBITDA Margin % compare to AIH and JYNT?
Genesis Healthcare's EBITDA Margin % of 4.10% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. Genesis Healthcare's value of 4.10% is 59.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genesis Healthcare's current EBITDA Margin % of 4.10% is 59.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Genesis Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genesis Healthcare's current EBITDA Margin % is 4.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genesis Healthcare stock overvalued right now?
Genesis Healthcare (GENNQ) has a current EBITDA Margin % of 4.10%. The current EBITDA Margin % is 4.10% and 59.8% below the Healthcare Providers & Services industry median of 10.21. Genesis Healthcare's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Genesis Healthcare (GENNQ), the current EBITDA Margin % is 4.10% as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genesis Healthcare Inc is a post-acute care provider in the United States. It focuses on the medical and physical issues facing elderly patients and is provided by the employees of skilled nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business. The company has three operating segments. The inpatient services segment include the operation of skilled nursing facilities and assisted/senior living facilities; rehabilitation therapy segment services include integrated and third-party rehabilitation and respiratory therapy services; and all other services. The majority of its revenue is generated from its skilled nursing facilities of the inpatient services segment.
12GF Score
Get the complete analysis for GENNQ
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GENNQ has been successfully added to your 
